• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体器官移植受者感染新型冠状病毒肺炎的结局

Outcomes of COVID-19 in Solid Organ Transplants.

作者信息

Ranabothu Saritha, Kanduri Swetha Rani, Nalleballe Krishna, Cheungpasitporn Wisit, Onteddu Sanjeeva, Kovvuru Karthik

机构信息

Pediatrics, University of Arkansas for Medical Sciences, Little Rock, USA.

Nephrology, Ochsner Medical Center, New Orleans, USA.

出版信息

Cureus. 2020 Nov 5;12(11):e11344. doi: 10.7759/cureus.11344.

DOI:10.7759/cureus.11344
PMID:33173653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7647837/
Abstract

The novel coronavirus disease 2019 (COVID-19) is a global pandemic affecting millions of people worldwide. Solid organ transplant (SOT) recipients are probably at higher risk of severe infection and associated complications from COVID-19. Data on clinical outcomes of COVID-19 infection in SOT recipients are limited. Using the TriNetX database, patients with laboratory-confirmed COVID-19 from January 20, 2020, to July 7, 2020, were included in the study. We compared clinical outcomes comprising hospitalization, need for critical care services, intubation, and mortality among SOT recipients and patients without SOT. Of 30,573 laboratory-confirmed COVID-19 patients, 288 had SOT. Patients with SOT were more likely to be hospitalized (37.2% vs. 12.2%; p < 0.0001), needed critical care services (6.9% vs. 2.3%; p < 0.0001), needed intubation (7.9% vs. 2.0%; p < 0.0001), and had a higher 30-day mortality (11.1% vs. 3.8%; p < 0.0001). Patients in the transplant group were older (55.4 vs. 47.6 years; p < 0.0001) and had a higher prevalence of medical co-morbidities. SOT recipients are at significant risk of adverse COVID-19 related outcomes, including hospitalization, need for critical care services, and 30-day mortality, likely due to multiple co-morbid conditions.

摘要

2019年新型冠状病毒病(COVID-19)是一场影响全球数百万人的大流行病。实体器官移植(SOT)受者感染COVID-19后发生严重感染及相关并发症的风险可能更高。关于SOT受者感染COVID-19的临床结局的数据有限。本研究使用TriNetX数据库,纳入了2020年1月20日至2020年7月7日实验室确诊为COVID-19的患者。我们比较了SOT受者和非SOT患者的临床结局,包括住院情况、重症监护服务需求、插管情况和死亡率。在30573例实验室确诊的COVID-19患者中,288例为SOT受者。SOT受者更有可能住院(37.2%对12.2%;p<0.0001)、需要重症监护服务(6.9%对2.3%;p<0.0001)、需要插管(7.9%对2.0%;p<0.0001),且30天死亡率更高(11.1%对3.8%;p<0.0001)。移植组患者年龄更大(55.4岁对47.6岁;p<0.0001),合并症患病率更高。SOT受者发生与COVID-19相关不良结局的风险显著,包括住院、需要重症监护服务和30天死亡率,这可能是由于多种合并症所致。

相似文献

1
Outcomes of COVID-19 in Solid Organ Transplants.实体器官移植受者感染新型冠状病毒肺炎的结局
Cureus. 2020 Nov 5;12(11):e11344. doi: 10.7759/cureus.11344.
2
Excess mortality in solid organ transplant recipients hospitalized with COVID-19: A large-scale comparison of SOT recipients hospitalized with or without COVID-19.COVID-19 住院患者中实体器官移植受者的超额死亡率:COVID-19 住院患者与非 COVID-19 住院患者的大规模比较。
Clin Transplant. 2022 Jan;36(1):e14492. doi: 10.1111/ctr.14492. Epub 2021 Oct 1.
3
A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients.一项与非实体器官移植患者相比 COVID-19 实体器官移植患者死亡率的倾向评分匹配分析。
PLoS One. 2021 Mar 3;16(3):e0247251. doi: 10.1371/journal.pone.0247251. eCollection 2021.
4
Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control Study.新型冠状病毒病 2019(COVID-19)在实体器官移植受者中的表现:一项病例对照研究。
Ann Transplant. 2021 Nov 12;26:e933152. doi: 10.12659/AOT.933152.
5
Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.因脓毒症和严重脓毒症住院的实体器官移植受者的住院死亡率。
Clin Infect Dis. 2016 Jul 15;63(2):186-94. doi: 10.1093/cid/ciw295. Epub 2016 May 23.
6
Hospitalization and survival of solid organ transplant recipients with coronavirus disease 2019: A propensity matched cohort study.COVID-19 住院患者和实体器官移植受者的生存情况:一项倾向评分匹配队列研究。
PLoS One. 2022 Dec 19;17(12):e0278781. doi: 10.1371/journal.pone.0278781. eCollection 2022.
7
Sepsis outcomes in solid organ transplant recipients.实体器官移植受者的脓毒症结局
Transpl Infect Dis. 2020 Feb;22(1):e13214. doi: 10.1111/tid.13214. Epub 2019 Dec 2.
8
Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients.COVID-19实体器官移植患者早期大流行期间的院内结局及死亡风险因素
Proc (Bayl Univ Med Cent). 2024 Mar 19;37(3):414-423. doi: 10.1080/08998280.2024.2325310. eCollection 2024.
9
Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database.艰难梭菌感染与住院实体器官移植受者结局的关联:来自2009年全国住院患者样本数据库的结果
Transpl Infect Dis. 2012 Oct;14(5):540-7. doi: 10.1111/j.1399-3062.2012.00761.x. Epub 2012 Jun 22.
10
Impact of solid organ transplant status on outcomes of hospitalized patients with COVID-19 infection.实体器官移植状态对 COVID-19 感染住院患者结局的影响。
Transpl Infect Dis. 2022 Aug;24(4):e13853. doi: 10.1111/tid.13853. Epub 2022 Jun 13.

引用本文的文献

1
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance.免疫抑制人群 COVID-19 死亡率的差异:加强疾病监测的系统评价和荟萃分析。
J Infect. 2024 Mar;88(3):106110. doi: 10.1016/j.jinf.2024.01.009. Epub 2024 Jan 30.
2
Integrated cell-free DNA and cytokine analysis uncovers distinct tissue injury and immune response patterns in solid organ transplant recipients with COVID-19.整合游离DNA和细胞因子分析揭示了COVID-19实体器官移植受者不同的组织损伤和免疫反应模式。
Res Sq. 2022 Jan 20:rs.3.rs-1262270. doi: 10.21203/rs.3.rs-1262270/v1.
3
Liver dysfunction and SARS-CoV-2 infection.肝功能障碍与 SARS-CoV-2 感染。
World J Gastroenterol. 2021 Jul 14;27(26):3951-3970. doi: 10.3748/wjg.v27.i26.3951.
4
Immunizations in Chronic Kidney Disease and Kidney Transplantation.慢性肾脏病与肾移植中的免疫接种
Curr Treat Options Infect Dis. 2021;13(2):47-65. doi: 10.1007/s40506-021-00248-7. Epub 2021 May 17.

本文引用的文献

1
Acute encephalopathy is associated with worse outcomes in COVID-19 patients.急性脑病与新冠病毒感染患者更差的预后相关。
Brain Behav Immun Health. 2020 Oct;8:100136. doi: 10.1016/j.bbih.2020.100136. Epub 2020 Sep 1.
2
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.COVID-19 与肾移植:TANGO 国际移植联合会的研究结果。
Am J Transplant. 2020 Nov;20(11):3140-3148. doi: 10.1111/ajt.16185. Epub 2020 Aug 4.
3
Spectrum of neuropsychiatric manifestations in COVID-19.新型冠状病毒肺炎的神经精神表现谱。
Brain Behav Immun. 2020 Aug;88:71-74. doi: 10.1016/j.bbi.2020.06.020. Epub 2020 Jun 17.
4
Spectrum of COVID-19 in children.儿童新型冠状病毒肺炎的疾病谱
Acta Paediatr. 2020 Sep;109(9):1899-1900. doi: 10.1111/apa.15412. Epub 2020 Jul 30.
5
COVID-19 in solid organ transplantation patients: A systematic review.实体器官移植患者中的新型冠状病毒肺炎:一项系统综述。
Clinics (Sao Paulo). 2020 Jun 3;75:e1983. doi: 10.6061/clinics/2020/e1983. eCollection 2020.
6
Underutilization of health care for strokes during the COVID-19 outbreak.2019冠状病毒病疫情期间中风医疗服务利用不足。
Int J Stroke. 2020 Jul;15(5):NP9-NP10. doi: 10.1177/1747493020934362. Epub 2020 Jun 18.
7
Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States.COVID-19 患者的实体器官移植受者的临床结果和血清学反应:来自美国的病例系列。
Am J Transplant. 2020 Nov;20(11):3225-3233. doi: 10.1111/ajt.16079. Epub 2020 Jul 17.
8
COVID-19: implications for immunosuppression in kidney disease and transplantation.COVID-19:对肾脏病和移植中免疫抑制的影响。
Nat Rev Nephrol. 2020 Jul;16(7):365-367. doi: 10.1038/s41581-020-0305-6.
9
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology.新型冠状病毒肺炎相关急性肾损伤:独特病理生理学的新证据
J Am Soc Nephrol. 2020 Jul;31(7):1380-1383. doi: 10.1681/ASN.2020040419. Epub 2020 May 4.
10
COVID-19 infection in kidney transplant recipients.肾移植受者中的 COVID-19 感染。
Kidney Int. 2020 Jun;97(6):1076-1082. doi: 10.1016/j.kint.2020.03.018. Epub 2020 Apr 9.